T0	Participants 28 113	Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention:
T1	Participants 272 297	acute coronary syndromes.
T2	Participants 529 662	patients on clopidogrel and high platelet reactivity undergoing percutaneous coronary intervention for acute coronary syndrome (ACS).
T3	Participants 672 689	Patients with ACS
T4	Participants 1129 1138	outcome).
T5	Participants 1139 1164	44 patients were enrolled